BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 21887927)

  • 41. A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child.
    Ahn JY; Seo YH; Park PW; Kim KH; Park MJ; Jeong JH; Park SH; Song YH
    Ann Lab Med; 2012 Mar; 32(2):162-6. PubMed ID: 22389885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
    De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
    Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
    Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
    Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
    Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
    Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS.
    Hüttl KS; Staiger AM; Richter J; Ott MM; Kalmbach S; Klapper W; Biesdorf AS; Trümper L; Rosenwald A; Ziepert M; Horn H; Ott G
    Virchows Arch; 2021 Sep; 479(3):575-583. PubMed ID: 33655392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.
    Masqué-Soler N; Szczepanowski M; Kohler CW; Aukema SM; Nagel I; Richter J; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2015 Nov; 171(4):501-8. PubMed ID: 26218299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
    Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
    J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome.
    Soldini D; Montagna C; Schüffler P; Martin V; Georgis A; Thiesler T; Curioni-Fontecedro A; Went P; Bosshard G; Dehler S; Mazzuchelli L; Tinguely M
    Ann Oncol; 2013 Jan; 24(1):193-201. PubMed ID: 22967991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis.
    Choi SY; Kim SJ; Kim WS; Kim K; Ko YH
    Virchows Arch; 2011 Nov; 459(5):495-502. PubMed ID: 22002677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions.
    Haralambieva E; Schuuring E; Rosati S; van Noesel C; Jansen P; Appel I; Guikema J; Wabinga H; Bleggi-Torres LF; Lam K; van den Berg E; Mellink C; van Zelderen-Bhola S; Kluin P
    Genes Chromosomes Cancer; 2004 May; 40(1):10-8. PubMed ID: 15034863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triple-hit B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma associated with a novel complex karyotype including t(2;3)(q21;q27), t(8;14)(q24;q32) and t(14;18)(q32;q21).
    Nakayama S; Yokote T; Iwaki K; Takayama A; Tsuji M; Hanafusa T
    Br J Haematol; 2013 Mar; 160(5):569. PubMed ID: 23205706
    [No Abstract]   [Full Text] [Related]  

  • 52. High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients.
    Nomura Y; Karube K; Suzuki R; Ying G; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Cancer Sci; 2008 Feb; 99(2):246-52. PubMed ID: 18271922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma.
    Pienkowska-Grela B; Witkowska A; Grygalewicz B; Rymkiewicz G; Rygier J; Woroniecka R; Walewski J
    Cancer Genet Cytogenet; 2005 Jan; 156(2):114-21. PubMed ID: 15642390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.
    Salaverria I; Siebert R
    J Clin Oncol; 2011 May; 29(14):1835-43. PubMed ID: 21482997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].
    Zhou J; Xia C; Shen Q; Yin H; Zhang X; Shi Q; Zhou X; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):8-14. PubMed ID: 24713242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection.
    Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffuse large B-cell lymphomas and burkitt lymphoma.
    de Leval L; Hasserjian RP
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):791-827. PubMed ID: 19577170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients.
    Gagnon MF; Bruehl FK; Sill DR; Meyer RG; Greipp PT; Hoppman NL; Xu X; Baughn LB; Peterson JF; McPhail ED; Ketterling RP; King RL
    J Hematop; 2024 Jun; 17(2):51-61. PubMed ID: 38561469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
    Hutchison RE; Finch C; Kepner J; Fuller C; Bowman P; Link M; Schwenn M; Laver J; Desai S; Barrett D; Murphy SB
    Ann Oncol; 2000; 11 Suppl 1():35-8. PubMed ID: 10707776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma.
    Schniederjan SD; Li S; Saxe DF; Lechowicz MJ; Lee KL; Terry PD; Mann KP
    Am J Clin Pathol; 2010 May; 133(5):718-26. PubMed ID: 20395518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.